Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 272

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 8
Chunk 272
---
 stock awards and incentive stock options. Our named executive officers who are full-time employees, like all other full-time employees, are eligible to participate in our retirement and health and welfare benefit plans. We will continue to evaluate our compensation values and philosophy and compensation plans and arrangements as circumstances merit. At a minimum, we review executive compensation annually with input from a compensation consultant. As part of this review process, we expect the board of directors and the compensation committee to apply our values and philosophy, while considering the compensation levels needed to ensure our executive compensation program remains competitive with our peers. In connection with our executive compensation program, we will also review whether we are meeting our retention objectives and the potential cost of replacing a key employee.

 75

Summary Compensation Table

The following table shows the total compensation awarded to, earned by, or paid to during the years ended December 31, 2024 and 2023 to our executive officers who earned more than $100,000 during each of the years ended December 31, 2024 and 2023 and were serving as named executive officers as of such date.

Our named executive officers for 2024 and 2023 who appear in the Summary Compensation Table are:

•James Rolke, our President and Chief Executive Officer; and

•Chester S. Zygmont, III, our Chief Financial Officer.

The following table sets forth, for the years ended December 31, 2024 and 2023, all compensation paid, distributed or earned for services, including salary and bonus amounts, rendered in all capacities by the Company’s named executive officers. The information contained below represents compensation earned by the Company’s officers for their work related to the Company:

    Non-equity incentive plan compensation ($)

    Name and Position
     
    Year
     
    Salary ($)
     
    Bonus ($)(1)
     
    Stock-based awards ($)
     
    Option-based awards ($)
     
    Annual incentive plans
     
    Long term incentive plans
     
    All other compensation ($)(2)
     
    Total compensation ($)

    James Rolke
     
    2024
     
    561,000
     
    237,500
     
    —
     
    —
     
    —
     
    —
     
    14,726
     
    813,226

    CEO
     
    2023
     
    475,000
     
    160,000
     
    —
     
    —
     
    —
     
    —
     
    14,250
     
    649,250